Related references
Note: Only part of the references are listed.Biselyngbyolide A, a Novel Cytotoxic Macrolide from the Marine Cyanobacterium Lyngbya sp.
Maho Morita et al.
CHEMISTRY LETTERS (2012)
Isolation and structures of biselyngbyasides B, C, and D from the marine cyanobacterium Lyngbya sp., and the biological activities of biselyngbyasides
Maho Morita et al.
TETRAHEDRON (2012)
Cyanobacteria: an emerging source for drug discovery
Rahul Kunwar Singh et al.
JOURNAL OF ANTIBIOTICS (2011)
Biselyngbyaside, a Macrolide Glycoside from the Marine Cyanobacterium Lyngbya sp.
Toshiaki Teruya et al.
ORGANIC LETTERS (2009)
2-Aminoethyl diphenylborinate analogues:: Selective inhibition for store-operated Ca2+ entry
Hong Zhou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Bioactive natural products from marine cyanobacteria for drug discovery
Lik Tong Tan
PHYTOCHEMISTRY (2007)
Bioorganic studies on marine natural products - Diverse chemical structures and bioactivities
Daisuke Uemura
CHEMICAL RECORD (2006)
Chemistry and biology of curacin A
P Wipf et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Somocystinamide A, a novel cytotoxic disulfide dimer from a Fijian marine cyanobacterial mixed assemblage
LM Nogle et al.
ORGANIC LETTERS (2002)
Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1
H Luesch et al.
JOURNAL OF NATURAL PRODUCTS (2001)
Share Paper
